Skip to main content
Premium Trial:

Request an Annual Quote

Partek, Krieger Institute Get $1.8M Grant for ASD, Schizophrenia Informatics Project

NEW YORK (GenomeWeb News) – Partek today said that it and the Kennedy Krieger Institute have been awarded a $1.8 million grant from the National Institutes of Health to develop commercial software that would identify chromosomal abnormalities underlying conditions such as autism spectrum disorder, bipolar disorder, and schizophrenia.

St. Louis-based Partek and Baltimore-based Kennedy Krieger Institute had previously collaborated on developing a mathematical method that combined two commonly used genotype association approaches to reveal genetic distinctions between individuals. They now plan to leverage that research and narrow their focus to families with one or more members affected by ASD.

Their initial goal is to identify individuals with ASD during infancy, but they also plan to use the same analysis tools for early diagnosis of mental health conditions including bipolar disorder and schizophrenia.

Further terms of the collaboration were not disclosed.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.